Literature DB >> 22703798

Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.

Joshua N Honeyman1, Barrie S Rich, Maureen P McEvoy, Molly A Knowles, Glenn Heller, Edward Riachy, Rachel Kobos, Neerav Shukla, Suzanne L Wolden, Peter G Steinherz, Michael P La Quaglia.   

Abstract

PURPOSE: Lymph node metastasis and anaplasia predict relapse-free survival in Wilms tumor. We performed a multivariate analysis of our institutional database to identify factors independently associated with relapse-free and overall survival.
METHODS: We retrospectively reviewed cases of confirmed Wilms tumor diagnosed between 1990 and 2010 and treated at our institution. The log-rank test was used to screen variables for consideration in the proportional hazards model.
RESULTS: A total of 95 patients were treated at our institution during the study period, with a median follow-up of 3.3 years. Factors correlated with overall survival in the univariate analysis were local disease, metastasis, tumor size, anaplasia, renal vein tumor thrombus, inferior vena cava tumor thrombus, lymph node positivity, and tumor rupture. On multivariate analysis, factors associated with increased risk of death were lymph node positivity and anaplasia. Factors correlated with probability of relapse in the univariate analysis were lymph node positivity, anaplasia, and female sex. All 3 of these factors were also independently significant on multivariate analysis.
CONCLUSION: Lymph node involvement and anaplasia are significantly correlated with probability of relapse and overall survival, reemphasizing the strong recommendation to sample regional lymph nodes during Wilms tumor resection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22703798     DOI: 10.1016/j.jpedsurg.2012.03.030

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor.

Authors:  Amanda F Saltzman; Derek E Smith; Dexiang Gao; Debashis Ghosh; Arya Amini; Jennifer H Aldrink; Roshni Dasgupta; Kenneth W Gow; Richard D Glick; Peter F Ehrlich; Nicholas G Cost
Journal:  J Pediatr Surg       Date:  2019-06-20       Impact factor: 2.545

2.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

3.  Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.

Authors:  Giovana T Torrezan; Elisa N Ferreira; Adriana M Nakahata; Bruna D F Barros; Mayra T M Castro; Bruna R Correa; Ana C V Krepischi; Eloisa H R Olivieri; Isabela W Cunha; Uri Tabori; Paul E Grundy; Cecilia M L Costa; Beatriz de Camargo; Pedro A F Galante; Dirce M Carraro
Journal:  Nat Commun       Date:  2014-06-09       Impact factor: 14.919

4.  Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.

Authors:  Ana Paula Percicote; Gabriel Lazaretti Mardegan; Elizabeth Schneider Gugelmim; Sergio Ossamu Ioshii; Ana Paula Kuczynski; Seigo Nagashima; Lúcia de Noronha
Journal:  Diagn Pathol       Date:  2018-01-22       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.